在生产加工及经营环节，严禁生产、经营存在添加非食用物质、农兽药残留超标、超范围超限量使用食 品添加剂等情形的肉类产品。严禁收购、贮存、销售、加工病死、毒死或者死因不明的畜禽肉类。严禁 在肉制品加工中掺杂掺假、以次充好，如使用鸡鸭肉冒充牛羊肉、以其他畜禽血产品假冒鸭血制品、使 用未切除"三腺"、病变淋巴结及病变组织的"槽头肉"等生产加工食品，欺骗消费者。严禁未按规定索取 查验动物产品检疫合格证明、肉品品质检验合格证。严禁未经许可或备案从事肉制品生产加工以及销售 来源不明的熟食、卤味等肉制品。严禁加工、销售未经检验检疫走私入境的冻品肉。 市场监管部门还提醒，严禁在网络交易平台或直播间对肉制品进行虚假宣传，并严禁销售"三无""山 寨"等假冒伪劣肉制品。 北京商报讯（记者 赵述评）严禁以其他畜禽血产品假冒鸭血制品、严禁用"槽头肉"生产加工食品、严 禁烧烤店大排档非法使用亚硝酸盐……4月21日，针对制售假劣肉制品问题，北京市启动了为期10个月 的专项整治行动，重点整治肉制品掺杂掺假、以假充真、虚假宣传等违法违规行为。北京市市场监督管 理局发布《关于规范肉制品生产经营行为的提醒告知书》（以下简称《提醒告知书》），并在全市 ...

Core Viewpoint - The company reported stable business performance in 2024 despite complex macroeconomic conditions, achieving total revenue of 59.715 billion yuan and a net profit of 4.989 billion yuan, with a slight decrease in net profit year-on-year [1][2]. Revenue and Profit Summary - Total revenue for 2024 reached 59.715 billion yuan, with a profit margin of 66.59 billion yuan, reflecting a year-on-year growth of 0.21% [1]. - The net profit attributable to shareholders was 4.989 billion yuan, showing a year-on-year decrease of 1.26% [1]. Business Segment Performance - The slaughtering business generated revenue of 30.334 billion yuan, accounting for 50.93% of total revenue, while the meat products segment contributed 24.788 billion yuan, representing 41.62% of total revenue [2]. - Despite a slight decline in revenue, the gross profit margin for the meat products segment increased by 4.01 percentage points [2]. - Other business segments reported revenue of 9.960 billion yuan, with a year-on-year growth of 10.44% and a gross profit margin increase of 2.11 percentage points [2]. Channel Development - The company had 21,282 distributors by the end of 2024, marking a 19.83% increase from the beginning of the year [1][3]. - The revenue share from the southern region of the Yangtze River increased to 21.786 billion yuan, accounting for 36.58% of total revenue, a growth of 2.27% compared to 2023 [3]. Market Trends and Opportunities - The concentration of the pig slaughtering industry in China reached 48.1% in 2024, indicating a trend towards larger-scale operations and improved efficiency [2][4]. - The increasing demand for pork, which remains the primary source of animal protein in the Chinese diet, is expected to support the company's stable growth [4]. Quality Control and Supply Chain Management - The company has established over 30 modern meat processing bases across 18 provinces, ensuring a stable supply of raw materials [5]. - The implementation of quality management systems such as ISO9001 and HACCP has strengthened the company's product quality control [5]. - A digital traceability system has been developed to enhance supply chain management, ensuring product quality and food safety [5]. Research and Development - In 2024, the company invested 937 million yuan in R&D, representing 1.57% of total revenue, with projects aimed at enhancing product quality and production efficiency [6]. - Completed R&D projects include key technologies for improving the quality of Chinese cuisine and precise preservation of fresh meat [6]. Shareholder Returns - The company plans to distribute a cash dividend of 7.50 yuan per 10 shares, totaling 2.598 billion yuan, which constitutes 64.8% of the distributable profits [1][6].